Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: Tobacco exposure as a risk modulator

Carcinogenesis

Volumn 28, Issue 7, 2007, Pages 1455-1462

  Anantharaman, Devasena ^a   Chaubal, Pranay M ^a   Kannan, Sadhana ^a   Bhisey, Rajani A ^b   Mahimkar, Manoj B ^a  

^a TATA MEMORIAL HOSPITAL   (India)

^b UNIVERSITY OF PUNE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A1; GENOMIC DNA; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; TOBACCO SMOKE;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHEEK MUCOSA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA EXTRACTION; ENVIRONMENTAL EXPOSURE; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HETEROZYGOTE; HIGH RISK PATIENT; HUMAN; INDIAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; NULL ALLELE; PERIPHERAL LYMPHOCYTE; POLYMERASE CHAIN REACTION; PRECANCER; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SMOKING; SMOKING HABIT; SQUAMOUS CELL CARCINOMA; TONGUE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; INCIDENCE; INDIA; MALE; MIDDLE AGED; MOUTH NEOPLASMS; POLYMORPHISM, GENETIC; TOBACCO; TOBACCO USE DISORDER;

EID: 34547743186     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgm038     Document Type: Article

References (51)

1. Parkin,D.M. et al. (2005) Global cancer statistics, 2002. CA Cancer J. Clin., 55, 74-108.
2. Notani,P.N. (2001) Global variation in cancer incidence and mortality. Curr. Sci., 81, 465-474.
3. Sankaranarayanan,R. et al. (1997) Chemoprevention of oral leukoplakia with vitamin A and beta carotene: An assessment. Oral Oncol., 33, 231-236.
4. IARC (1985) Tobacco habits other than smoking; betel-quid and areca-nut chewing; and some related nitrosamines. IARC Working Group. Lyon, 23-30 October 1984. IARC Monogr. Eval. Carcinog. Risk Chem. Hum., 37 1-268.
5. Hecht,S.S. (2003) Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat. Rev. Cancer, 3, 733-744.
6. Bhide,S.V. et al. (1986) N-nitrosamines in the saliva of tobacco chewers or masheri users. Food Chem. Toxicol., 24, 293-297.
7. Nair,U.J. et al. (1999) Glutathione S-transferase M1 and T1 null genotypes as risk factors for oral leukoplakia in ethnic Indian betel quid/tobacco chewers. Carcinogenesis, 20, 743-748.
8. Bartsch,H. et al. (2000) Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol. Biomarkers Prev., 9, 3-28.
9. Petersen,D.D. et al. (1991) Human CYP1A1 gene: Cosegregation of the enzyme inducibility phenotype and an RFLP. Am. J. Hum. Genet. 48, 720-725.
10. Tanimoto,K. et al. (1999) Polymorphism of the CYP1A1 and GSTM1 gene involved in oral squamous cell carcinoma in association with a cigarette dose. Oral Oncol., 35, 191-196.
11. Strange,R.C. et al. (2001) Glutathione-S-transferase family of enzymes. Mutat. Res., 482, 21-26.
12. Kim,W.J. et al. (2002) GSTT1-null genotype is a protective factor against bladder cancer. Urology, 60, 913-918.
13. Parl,F.F. (2005) Glutathione S-transferase genotypes and cancer risk. Cancer Lett., 221, 123-129.
14. Buch,S.C. et al. (2002) Polymorphism at GSTM1, GSTM3 and GSTT1 gene loci and susceptibility to oral cancer in an Indian population. Carcinogenesis, 23, 803-807.
15. Hashibe,M. et al. (2003) Meta- and pooled analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes and risk of head and neck cancer. Cancer Epidemiol. Biomarkers Prev., 12, 1509-1517.
16. Drummond,S.N. et al. (2004) GSTM1 polymorphism and oral squamous cell carcinoma. Oral Oncol., 40, 52-55.
17. Drummond,S.N. et al. (2005) Association between GSTT-1 gene deletion and the susceptibility to oral squamous cell carcinoma in cigarette-smoking subjects. Oral Oncol., 41, 515-519.
18. Evans.A.J. et al. (2004) Polymorphisms of GSTT1 and related genes in head and neck cancer risk. Head Neck, 26, 63-70.
19. Sato,M. et al. (1999) Genetic polymorphism of drug-metabolizing enzyme and susceptibility to oral cancer. Carcinogenesis, 20 1927-1931.
20. Sikdar,N. et al. (2004) Glutathione S-transferase M3 (A/A) genotype as a risk factor for oral cancer and leukoplakia among Indian tobacco smokers. Int. J. Cancer, 109, 95-101.
21. Xie,H. et al. (2004) Metabolic polymorphisms, smoking, and oral cancer in Puerto Rico. Oncol. Res., 14, 315-320.
22. Kotekar,A. et al. (2002) CYP1A1*2 and CYP1A1*3 polymorphisms cosegregate in the Indian population. Anthropol. Anz. 60, 255-260.
23. Sikdar,N. et al. (2003) Polymorphism in CYP1A1 and CYP2E1 genes and susceptibility to leukoplakia in Indian tobacco users. Cancer Lett., 195, 33-42.
24. Naveen,A.T. et al. (2004) Glutathione S-transferase M1 and T1 null genotype distribution in South Indians. Eur. J. Clin. Pharmacol., 60, 403-406.
25. Sreelekha,T.T. et al. (2001) Genetic polymorphisin of CYP1A1, GSTM1 and GSTT1 genes in Indian oral cancer. Oral Oncol., 37, 593-598.
26. Srivastava,D.S. et al. (2005) Genetic polymorphism of glutathione S-transferase genes (GSTM1, GSTT1 and GSTP1) and susceptibility to prostate cancer in Northern India. Br. J. Urol. Int., 95, 170-173.
27. Vondracek,M. et al. (2001) Cytochrome P450 expression and related metabolism in human buccal mucosa. Carcinogenesis, 22, 481-488.
28. Gronau,S. et al. (2003) Gene polymorphisms in detoxification enzymes as susceptibility factor for head and neck cancer? Otolaryngol. Head Neck Surg., 128, 674-680.
29. Katoh,T. et al. (1999) Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and oral cavity cancer. Int. J. Cancer, 83, 606-609.
30. Matthias,C. et al. (1998) The glutathione S-transferase GSTP1 polymorphism: Effects on susceptibility to oral/pharyngeal and laryngeal carcinomas. Pharmacogenetics, 8, 1-6.
31. Deng,Z.L. et al. (2004) Frequent genetic deletion of detoxifying enzyme GSTM1 and GSTT1 genes in nasopharyngeal carcinoma patients in Guangxi Province, China. Zhonghua Zhong Liu Za Zhi, 26, 598-600.
32. Geisler,S.A. et al. (2005) Glutathione S-transferase polymorphisms and survival from head and neck cancer. Head Neck, 27, 232-242.
33. Norppa,H. (2004) Cytogenetic biomarkers and genetic polymorphisms. Toxicol. Lett., 149, 309-334.
34. Cheng,T.J. et al. (1995) Comparison of sister chromatid exchange frequency in peripheral lymphocytes in lung cancer cases and controls. Mutat. Res., 348, 75-82.
35. Barroso Duarte,E.C. et al. (2006) GSTT1 polymorphism and oral leukoplakia. Anticancer Res., 26, 427-430.
36. Garcia-Closas,M. et al. (1999) Glutathione S-transferase mu and theta polymorphisms and breast cancer susceptibility. J. Natl. Cancer Inst., 91, 1960-1964.
37. Landi,S. (2000) Mammalian class theta GST and differential susceptibility to carcinogens: A review. Mutat. Res., 463, 247-283.
38. Shimada,T. et al. (1996) Activation and inactivation of carcinogenic dihaloalkanes and other compounds by glutathione S-transferase 5-5 in Salmonella typhimurium tester strain NM5004. Chem. Res. Toxicol., 9, 333-340.
39. Salama,S.A. et al. (1999) Role of polymorphic GSTM1 and GSTT1 genotypes on NNK-induced genotoxicity. Pharmacogenetics, 9, 735-743.
40. Norppa,H. (2004) Cytogenetic biomarkers. IARC Sci. Publ., 179-205.
41. Wiencke,J.K. et al. (1995) Gene deletion of glutathione S-transferase theta: Correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiol. Biomarkers Prev., 4, 253-259.
42. Chen,Y.K. et al. (1997) Evaluation of glutathione S-transferase activity in human buccal epithelial dysplasias and squamous cell carcinomas. Int. J. Oral Maxillofac. Surg., 26, 205-209.
43. Patol,B.P. et al. (2005) Study of tobacco habits and alterations in enzymatic antioxidant system in oral cancer. Oncology, 68 511-519.
44. Adler,V. et al. (1999) Regulation of JNK signaling by GSTp. EMBO J. 18, 1321-1334.
45. Townsend,D.M. et al. (2005) Glutathione S-transferases as regulators of kinase, pathways and anticancer drug targets. Methods Enzymol., 401, 287-307.
46. McIlwain,C.C. et al. (2006) Glutathione S-transferase polymorphisms: Cancer incidence and therapy. Oncogene, 25, 1639-1648.
47. Pradhan,S.A. (1991) Gingivo-buccal cancer: The Indian ond cancer. Oral Cancer, 63-76.
48. Presland,R.B. et al. (2000) Epithelial structural proteins of the skin and oral cavity: Function in health and disease. Crit. Rev. Oral Biol. Med., 11, 383-408.
49. Ogden,G.R. et al. (1994) DNA and keratin analysis of oral exfoliative cytology in the detection of oral cancer. Eur. J. Cancer B Oral Oncol., 30B, 405-408.
50. Huang,Q. et al. (2002) Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: Construction of oncogenetic trees for tumor progression. Genes Chromosomes Cancer, 34, 224-233.
51. Pelkonen,O. et al. (1997) Metabolic activation of toxins: tissue-specific expression and metabolism in target organs. Environ. Health Perspect., 105 (suppl. 4), 767-774.